Seya T - Search Results

1

Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control study.

Kodama K, Higashiyama M, Takami K, Oda K, Okami J, Maeda J, Akazawa T, Matsumoto M, Seya T, Wada M, Toyoshima K. Kodama K, et al. Among authors: seya t. Surg Today. 2009;39(3):194-200. doi: 10.1007/s00595-008-3826-3. Epub 2009 Mar 12. Surg Today. 2009. PMID: 19280277

2

Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.

Seya T, Hara T, Okada M, Kojima A, Matsumoto M, Akedo H. Seya T, et al. Int Immunol. 1992 Dec;4(12):1361-71. doi: 10.1093/intimm/4.12.1361. Int Immunol. 1992. PMID: 1283697

3

Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies.

Hara T, Kojima A, Fukuda H, Masaoka T, Fukumori Y, Matsumoto M, Seya T. Hara T, et al. Among authors: seya t. Br J Haematol. 1992 Oct;82(2):368-73. doi: 10.1111/j.1365-2141.1992.tb06431.x. Br J Haematol. 1992. PMID: 1384649

4

Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).

Masaki T, Matsumoto M, Nakanishi I, Yasuda R, Seya T. Masaki T, et al. Among authors: seya t. J Biochem. 1992 May;111(5):573-8. doi: 10.1093/oxfordjournals.jbchem.a123799. J Biochem. 1992. PMID: 1386357 Free article.

5

Soluble forms of membrane cofactor protein (CD46, MCP) are present in plasma, tears, and seminal fluid in normal subjects.

Hara T, Kuriyama S, Kiyohara H, Nagase Y, Matsumoto M, Seya T. Hara T, et al. Among authors: seya t. Clin Exp Immunol. 1992 Sep;89(3):490-4. doi: 10.1111/j.1365-2249.1992.tb06986.x. Clin Exp Immunol. 1992. PMID: 1516264 Free PMC article.

6

Effect of anticomplement reagents, K-76 COOH and FUT175, on discordant xenograft survival.

Miyagawa S, Shirakura R, Matsumiya G, Kitagawa S, Fukushima N, Nakata S, Nakano S, Kitamura H, Matsumoto M, Seya T, et al. Miyagawa S, et al. Among authors: seya t. Transplant Proc. 1992 Apr;24(2):483-4. Transplant Proc. 1992. PMID: 1566397 No abstract available.

7

Proteolytic elimination of decay-accelerating factor (DAF): lytic abnormality coincides with removal of DAF in papain-treated human erythrocytes.

Seya T, Inoue H, Okada M, Matsumoto M, Kitamura H, Kinoshita T, Akedo H. Seya T, et al. Mol Immunol. 1990 Jan;27(1):69-78. doi: 10.1016/0161-5890(90)90061-4. Mol Immunol. 1990. PMID: 1690349

8

Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.

Seya T, Hara T, Matsumoto M, Akedo H. Seya T, et al. J Immunol. 1990 Jul 1;145(1):238-45. J Immunol. 1990. PMID: 1694203

9

Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.

Matsumoto M, Sugita Y, Seya T. Matsumoto M, et al. Among authors: seya t. Eur J Immunol. 1991 Aug;21(8):1787-92. doi: 10.1002/eji.1830210802. Eur J Immunol. 1991. PMID: 1714391

10

Deficiency of complement decay-accelerating factor (DAF, CD55) in non-Hodgkin's lymphoma.

Fukuda H, Seya T, Hara T, Matsumoto M, Kinoshita T, Masaoka T. Fukuda H, et al. Among authors: seya t. Immunol Lett. 1991 Aug;29(3):205-9. doi: 10.1016/0165-2478(91)90171-6. Immunol Lett. 1991. PMID: 1722775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters